tiprankstipranks
Qiagen NV (QGEN)
NYSE:QGEN
US Market
QGEN
Qiagen
RESEARCH TOOLSreports
Want to see QGEN full AI Analyst Report?

Qiagen (QGEN) Stock Forecast & Price Target

430 Followers
See the Price Targets and Ratings of:

QGEN Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
6 Buy
7 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Qiagen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QGEN Stock 12 Month Forecast

Average Price Target

$45.28
▲(9.79% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is $45.28 with a high forecast of $58.36 and a low forecast of $38.00. The average price target represents a 9.79% change from the last price of $41.24.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"37":"$37","48":"$48","59":"$59","42.5":"$42.5","53.5":"$53.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":58.3628,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$58.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45.277227636363634,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$45.28</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$38.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[37,42.5,48,53.5,59],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.38,41.76329230769231,43.14658461538462,44.52987692307693,45.913169230769235,47.29646153846154,48.679753846153844,50.06304615384616,51.44633846153846,52.829630769230775,54.212923076923076,55.596215384615384,56.97950769230769,{"y":58.3628,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.38,40.75670981818182,41.13341963636364,41.510129454545456,41.88683927272727,42.263549090909095,42.64025890909091,43.016968727272726,43.39367854545454,43.770388363636364,44.14709818181818,44.523807999999995,44.90051781818182,{"y":45.277227636363634,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40.38,40.19692307692308,40.01384615384615,39.830769230769235,39.64769230769231,39.464615384615385,39.28153846153846,39.09846153846154,38.91538461538462,38.73230769230769,38.54923076923077,38.36615384615385,38.183076923076925,{"y":38,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":39.361,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.051,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.742,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.023,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.578,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.397,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.928,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.419,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.045,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.18,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.83,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.38,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$58.36Average Price Target$45.28Lowest Price Target$38.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DZ BANK AG Analyst forecast on QGEN
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
04/29/26
Qiagen (QGEN) Gets a Buy from DZ BANK AG
Robert W. Baird Analyst forecast on QGEN
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$53→$43
Buy
4.27%
Upside
Upgraded
04/29/26
Qiagen upgraded to Outperform from Neutral at BairdQiagen upgraded to Outperform from Neutral at Baird
Morgan Stanley Analyst forecast on QGEN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$51.36→$39.69
Hold
-3.77%
Downside
Reiterated
04/29/26
Qiagen price target lowered to EUR 34 from EUR 44 at Morgan StanleyQiagen price target lowered to EUR 34 from EUR 44 at Morgan Stanley
Citi Analyst forecast on QGEN
Patrick B Donnelly
Citi
Citi
$55→$38
Hold
-7.86%
Downside
Reiterated
04/29/26
Qiagen price target lowered to $38 from $55 at CitiQiagen price target lowered to $38 from $55 at Citi
J.P. Morgan Analyst forecast on QGEN
Casey Woodring
J.P. Morgan
J.P. Morgan
$60→$45
Buy
9.12%
Upside
Reiterated
04/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)
Barclays Analyst forecast on QGEN
Luke Sergott
Barclays
Barclays
$44→$38
Hold
-7.86%
Downside
Reiterated
04/29/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and BridgeBio Pharma (NASDAQ: BBIO)
Jefferies Analyst forecast on QGEN
Tycho Peterson
Jefferies
Jefferies
―
Buy
―
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS) and Qiagen (NYSE: QGEN)
William Blair Analyst forecast on QGEN
Andrew Brackmann
William Blair
William Blair
$38
Hold
-7.86%
Downside
Reiterated
04/28/26
Qiagen Kept at Hold as Guidance Cut and QuantiFERON Weakness Offset H2 Rebound Hopes and Heighten Execution Risk
Stifel Nicolaus Analyst forecast on QGEN
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$50
Hold
21.24%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN), Eli Lilly & Co (NYSE: LLY) and Janux Therapeutics Inc (NASDAQ: JANX)
Deutsche Bank Analyst forecast on QGEN
Jan Koch
Deutsche Bank
Deutsche Bank
$54→$43
Buy
4.27%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN), Sionna Therapeutics, Inc. (NASDAQ: SION) and Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)
Berenberg Bank Analyst forecast on QGEN
Harry Gillis
Berenberg Bank
Berenberg Bank
$53.69→$58.36
Buy
41.52%
Upside
Reiterated
02/12/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Humana (NYSE: HUM)
UBS Analyst forecast on QGEN
Dan Leonard
UBS
UBS
$52
Hold
26.09%
Upside
Reiterated
02/09/26
Qiagen: Slower Core Growth and Back-Half-Loaded Targets Keep Risk/Reward Balanced at Hold
TD Cowen Analyst forecast on QGEN
Daniel Brennan
TD Cowen
TD Cowen
$48→$53
Hold
28.52%
Upside
Reiterated
02/04/26
Qiagen: Solid Long‑Term Fundamentals but Near‑Term Headwinds Justify Hold Rating
Nephron Analyst forecast on QGEN
Jack Meehan
Nephron
Nephron
$59
Hold
43.06%
Upside
Downgraded
01/21/26
Qiagen downgraded to Hold from Buy at Nephron ResearchQiagen downgraded to Hold from Buy at Nephron Research
Bank of America Securities Analyst forecast on QGEN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$55.79
Buy
35.28%
Upside
Reiterated
12/15/25
Bank of America Securities Sticks to Their Buy Rating for Qiagen (QGEN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
DZ BANK AG Analyst forecast on QGEN
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
04/29/26
Qiagen (QGEN) Gets a Buy from DZ BANK AG
Robert W. Baird Analyst forecast on QGEN
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$53→$43
Buy
4.27%
Upside
Upgraded
04/29/26
Qiagen upgraded to Outperform from Neutral at BairdQiagen upgraded to Outperform from Neutral at Baird
Morgan Stanley Analyst forecast on QGEN
Aisyah Noor
Morgan Stanley
Morgan Stanley
$51.36→$39.69
Hold
-3.77%
Downside
Reiterated
04/29/26
Qiagen price target lowered to EUR 34 from EUR 44 at Morgan StanleyQiagen price target lowered to EUR 34 from EUR 44 at Morgan Stanley
Citi Analyst forecast on QGEN
Patrick B Donnelly
Citi
Citi
$55→$38
Hold
-7.86%
Downside
Reiterated
04/29/26
Qiagen price target lowered to $38 from $55 at CitiQiagen price target lowered to $38 from $55 at Citi
J.P. Morgan Analyst forecast on QGEN
Casey Woodring
J.P. Morgan
J.P. Morgan
$60→$45
Buy
9.12%
Upside
Reiterated
04/29/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)
Barclays Analyst forecast on QGEN
Luke Sergott
Barclays
Barclays
$44→$38
Hold
-7.86%
Downside
Reiterated
04/29/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and BridgeBio Pharma (NASDAQ: BBIO)
Jefferies Analyst forecast on QGEN
Tycho Peterson
Jefferies
Jefferies
―
Buy
―
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS) and Qiagen (NYSE: QGEN)
William Blair Analyst forecast on QGEN
Andrew Brackmann
William Blair
William Blair
$38
Hold
-7.86%
Downside
Reiterated
04/28/26
Qiagen Kept at Hold as Guidance Cut and QuantiFERON Weakness Offset H2 Rebound Hopes and Heighten Execution Risk
Stifel Nicolaus Analyst forecast on QGEN
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$50
Hold
21.24%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN), Eli Lilly & Co (NYSE: LLY) and Janux Therapeutics Inc (NASDAQ: JANX)
Deutsche Bank Analyst forecast on QGEN
Jan Koch
Deutsche Bank
Deutsche Bank
$54→$43
Buy
4.27%
Upside
Reiterated
04/28/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN), Sionna Therapeutics, Inc. (NASDAQ: SION) and Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)
Berenberg Bank Analyst forecast on QGEN
Harry Gillis
Berenberg Bank
Berenberg Bank
$53.69→$58.36
Buy
41.52%
Upside
Reiterated
02/12/26
Analysts Offer Insights on Healthcare Companies: Qiagen (NYSE: QGEN) and Humana (NYSE: HUM)
UBS Analyst forecast on QGEN
Dan Leonard
UBS
UBS
$52
Hold
26.09%
Upside
Reiterated
02/09/26
Qiagen: Slower Core Growth and Back-Half-Loaded Targets Keep Risk/Reward Balanced at Hold
TD Cowen Analyst forecast on QGEN
Daniel Brennan
TD Cowen
TD Cowen
$48→$53
Hold
28.52%
Upside
Reiterated
02/04/26
Qiagen: Solid Long‑Term Fundamentals but Near‑Term Headwinds Justify Hold Rating
Nephron Analyst forecast on QGEN
Jack Meehan
Nephron
Nephron
$59
Hold
43.06%
Upside
Downgraded
01/21/26
Qiagen downgraded to Hold from Buy at Nephron ResearchQiagen downgraded to Hold from Buy at Nephron Research
Bank of America Securities Analyst forecast on QGEN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$55.79
Buy
35.28%
Upside
Reiterated
12/15/25
Bank of America Securities Sticks to Their Buy Rating for Qiagen (QGEN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

3 Months
xxx
Success Rate
7/14 ratings generated profit
50%
Average Return
+1.35%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.35% per trade.
1 Year
Tycho PetersonJefferies
Success Rate
9/19 ratings generated profit
47%
Average Return
-1.99%
Copying Tycho Peterson's trades and holding each position for 1 Year would result in 47.37% of your transactions generating a profit, with an average return of -1.99% per trade.
2 Years
xxx
Success Rate
3/17 ratings generated profit
18%
Average Return
-13.00%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 17.65% of your transactions generating a profit, with an average return of -13.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QGEN Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
13
16
13
12
13
Hold
7
12
17
15
16
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
28
30
27
29
In the current month, QGEN has received 13 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. QGEN average Analyst price target in the past 3 months is 45.28.
Each month's total comprises the sum of three months' worth of ratings.

QGEN Financial Forecast

QGEN Earnings Forecast

Next quarter’s earnings estimate for QGEN is $0.61 with a range of $0.60 to $0.62. The previous quarter’s EPS was $0.54. QGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for QGEN is $0.61 with a range of $0.60 to $0.62. The previous quarter’s EPS was $0.54. QGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.

QGEN Sales Forecast

Next quarter’s sales forecast for QGEN is $537.16M with a range of $526.73M to $554.00M. The previous quarter’s sales results were $523.30M. QGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.
Next quarter’s sales forecast for QGEN is $537.16M with a range of $526.73M to $554.00M. The previous quarter’s sales results were $523.30M. QGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QGEN has Performed in-line its overall industry.

QGEN Stock Forecast FAQ

What is QGEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Qiagen NV’s 12-month average price target is 45.28.
    What is QGEN’s upside potential, based on the analysts’ average price target?
    Qiagen NV has 9.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is QGEN a Buy, Sell or Hold?
          Qiagen NV has a consensus rating of Moderate Buy which is based on 6 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Qiagen NV’s price target?
            The average price target for Qiagen NV is 45.28. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $58.36 ,the lowest forecast is $38.00. The average price target represents 9.79% Increase from the current price of $41.24.
              What do analysts say about Qiagen NV?
              Qiagen NV’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of QGEN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.